Fortrea Reinstates Knoblauch as CFO After Legal Dispute With Former Employer
By Kelly Cloonan
Fortrea Holdings reinstated Jason Knoblauch as chief financial officer following a legal dispute with his former employer.
Knoblauch had initially joined the contract-research company in July. He was placed on a paid leave of absence later that month after a Delaware court granted a temporary restraining order preventing him from working in the role after his prior employer filed a lawsuit alleging he violated certain restrictive covenants and retained confidential information.
Knoblauch previously worked at Clario, an endpoint data-solutions provider in the clinical-trials industry, which was acquired by Thermo Fisher Scientific in March.
David Smith, a director on Fortrea's board, had been CFO on an interim basis during Knoblauch's leave.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
September 10, 2026 08:27 ET (12:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
